Invivyd (IVVD) Amortizatization of Intangibles (2021 - 2023)

Invivyd (IVVD) posted Amortizatization of Intangibles of -$5.1 million for Q4 2023, down 403.43% on a QoQ basis from $1.7 million in Q3 2023, and down 342.74% year-over-year from $2.1 million in Q4 2022.

Invivyd (IVVD) Amortizatization of Intangibles (2021 - 2023) Analysis & Trends

Invivyd's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at -$5.1 million for Q4 2023.

  • Quarterly Amortizatization of Intangibles fell 342.74% year-over-year to -$5.1 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$5.1 million (down 161.33% YoY) and the FY2023 annual result came in at $1.1 million, down 44.54% from the prior year.
  • Amortizatization of Intangibles was -$5.1 million for Q4 2023 at Invivyd, down from $1.7 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.5 million in Q1 2023 and bottomed at -$5.1 million in Q4 2023.
  • A 3-year average of $190555.6 and a median of $577000.0 in 2021 frame the typical range for Amortizatization of Intangibles.
  • Peak annual rise in Amortizatization of Intangibles reached 1558.82% in 2023, while the deepest fall reached 342.74% in 2023.
  • Invivyd's Amortizatization of Intangibles stood at -$2.0 million in 2021, then jumped by 205.38% to $2.1 million in 2022, then slumped by 342.74% to -$5.1 million in 2023.
  • Business Quant data shows IVVD's Amortizatization of Intangibles at -$5.1 million in Q4 2023, $1.7 million in Q3 2023, and $2.0 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Invivyd 104.07 Mn -122.62 Mn 16.07 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 -5.13 Mn
Dec 31, 2023 -5.13 Mn
Sep 30, 2023 1.69 Mn
Sep 30, 2023 1.69 Mn
Jun 30, 2023 2.02 Mn
Jun 30, 2023 2.02 Mn
Mar 31, 2023 2.54 Mn
Mar 31, 2023 2.54 Mn
Dec 31, 2022 2.12 Mn
Dec 31, 2022 2.12 Mn
Sep 30, 2022 102,000.00
Sep 30, 2022 102,000.00
Mar 31, 2022 -194,000.00
Mar 31, 2022 -194,000.00
Dec 31, 2021 -2.01 Mn
Dec 31, 2021 -2.01 Mn
Sep 30, 2021 577,000.00
Sep 30, 2021 577,000.00